EUVIMEDSkopri EUVIMED
EUVIMED · CrossrefJournal

Expert Opinion on Biological Therapy

ISSN 1471-2598 · Informa UK Limited

Latest articles

  1. Machine learning-integrated explainable artificial intelligence for survival prediction in urothelial carcinoma with enfortumab vedotin: an exploratory real-world analysis

    Kannan Sridharan, Ondrej Fiala, Gowri Sivaramakrishnan, Marc R. Matrana, Thomas Büttner, Jakub Kucharz, Javier Molina Cerrillo, Patrizia Giannatempo, Zin W. Myint, Alfonso Gómez de Liaño, Alina Pirshtuk, Augusto Mota, Ravindran Kanesvaran, Yüksel Ürün, Martin Angel, Tomas Soule, Francesco Massari, Joaquim Bellmunt, Shilpa Gupta, Matteo Santoni

    Published: 2026-10-03DOI: 10.1080/14712598.2026.2727098

  2. Real-world effectiveness and drug retention rate of risankizumab in patients with psoriatic arthritis: data from the multicentre GIRRCS cohort

    Francesco Caso, Eleonora Celletti, Ilenia Pantano, Francesco Maria Mariani, Azadeh Shariat Panahi, Myriam Di Penta, Riccardo Mattia Ricciardi, Alberto Lo Gullo, Daniele Mauro, Francesca Saracino, Francesco Ursini, Luisa Costa, Raffaele Scarpa, Roberto Giacomelli, Francesco Ciccia, Giuliana Guggino, Paola Cipriani, Piero Ruscitti

    Published: 2026-10-03DOI: 10.1080/14712598.2026.2736542

Volumes

2026 · 1302025 · 1272024 · 1332023 · 1312022 · 1432021 · 1532020 · 1492019 · 1282018 · 1552017 · 1472016 · 1422015 · 1912014 · 1752013 · 1782012 · 1892011 · 1432010 · 1492009 · 1432008 · 1722007 · 1632006 · 1182005 · 1412004 · 2492003 · 2302002 · 912001 · 85

Għarfien li jaqbel max-xogħol tiegħek.

Minn bidu b’xejn u riċerka personali tal-letteratura sal-Research Suite sħiħa.

Ara t-tariffi →

Il-full texts kollha tal-pubblikaturi huma inklużi?

Le. Ir-referenzi biblijografiċi, l-astratti u t-testi sħaħ huma kontenuti differenti. Jekk test sħiħ huwiex disponibbli jiddependi mis-sors, Open Access u l-liċenzji eżistenti tiegħek. Pjan ta’ EUVIMED ma jissostitwix drittijiet addizzjonali tal-pubblikaturi.